Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineNo recent work listed

Chengbin Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9672-7412; OpenAlex author ID A5021422436. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2014: 2 papers · 2015: 3 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: 1 paper

Papers 11

  1. Synthetic Conjugated Oligoelectrolytes Are Effective siRNA Transfection Carriers: Relevance to Pancreatic Cancer Gene Therapy. Co-author DOI 10.1021/acs.biomac.1c01498↗
  2. A novel P38α MAPK activator Bruceine A exhibits potent anti-pancreatic cancer activity. Co-author DOI 10.1016/j.csbj.2021.06.011↗
  3. Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer. Co-author DOI 10.1016/j.phrs.2021.105658↗
  4. Carbon Dioxide-Derived Biodegradable and Cationic Polycarbonates as a New siRNA Carrier for Gene Therapy in Pancreatic Cancer. Last author DOI 10.3390/nano11092312↗
  5. Biodegradable Polymer-Coated Multifunctional Graphene Quantum Dots for Light-Triggered Synergetic Therapy of Pancreatic Cancer. Co-author DOI 10.1021/acsami.8b16168↗
  6. Biodegradable nanoparticles as siRNA carriers for in vivo gene silencing and pancreatic cancer therapy. Co-author DOI 10.1039/c6tb03116a↗
  7. Biodegradable nanoparticle-mediated K-ras down regulation for pancreatic cancer gene therapy. Co-author DOI 10.1039/c4tb01623h↗
  8. RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles. First author DOI 10.1088/0957-4484/26/36/365101↗
  9. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA. First author DOI 10.7150/thno.11335↗
  10. Interleukin-8 gene silencing on pancreatic cancer cells using biodegradable polymer nanoplexes. First author DOI 10.1039/c3bm60325c↗
  11. Pancreatic cancer gene therapy using an siRNA-functionalized single walled carbon nanotubes (SWNTs) nanoplex. Co-author DOI 10.1039/c4bm00019f↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ken‐Tye Yong · 9 shared papers, 2014–2022 · strength 0.64
  2. Guimiao Lin · 5 shared papers, 2014–2019 · strength 0.27
  3. Weiwei Tao · 2 shared papers, 2021 · strength 0.25
  4. Ming Zhao · 2 shared papers, 2021 · strength 0.25
  5. Lu Cai · 2 shared papers, 2021 · strength 0.25
  6. Pengfei Zhang · 2 shared papers, 2021 · strength 0.25
  7. Feng Yin · 3 shared papers, 2015–2017 · strength 0.16
  8. Guillermo Carlos Bazan · 1 shared paper, 2022 · strength 0.15
  9. Tommy Anderson · 3 shared papers, 2014–2015 · strength 0.14
  10. Xiang Li · 1 shared paper, 2021 · strength 0.11
  11. Xinmeng Zhang · 1 shared paper, 2021 · strength 0.11
  12. Nishtha Panwar · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.